Latest Regulatory Approvals News

TMK Energy Limited has announced a significant security consolidation, merging every 55 existing securities into one, impacting shares, options, and performance rights with adjusted exercise prices.

Elanor Investors Group has obtained a crucial ASX waiver allowing a longer timeframe to issue securities tied to its $125 million recapitalisation with Rockworth Investment. This move addresses regulatory delays and aims to stabilise Elanor's balance sheet and reduce gearing.

EV Resources Limited has acquired the high-grade Milton Canyon Antimony Project in Nevada, reinforcing its strategy to supply critical minerals to the U.S. market. This move complements its existing assets in Nevada and Mexico, aligning with U.S. government priorities for secure antimony sources.

INOVIQ Limited has obtained exclusive worldwide rights to novel ovarian cancer biomarker IP from UniQuest, propelling its EXO-OC™ test closer to commercial launch. The test’s exceptional sensitivity and specificity position it as a potential breakthrough in early cancer detection.

Caravel Minerals has released its first comprehensive Sustainability Report for fiscal 2025, detailing ambitious ESG initiatives and a clear roadmap toward net-zero emissions for its Caravel Copper Project in Western Australia.

Audalia Resources is raising $500,000 through a share placement to fund critical development and regulatory steps at its Medcalf Project, aiming to advance mining permits and design.

Tamboran Resources has reported record natural gas flow rates from its Shenandoah South 2H sidetrack well and initiated the largest drilling program ever seen in the Beetaloo Basin, alongside securing key approvals for gas sales.

News Corporation has updated its dividend details for the six months ending June 2025, confirming an ordinary unfranked dividend of USD 0.10 per Class A non-voting common stock CDI, payable in both US and Australian dollars.

Paterson Resources has announced a $2 million capital raising via a placement and a non-renounceable entitlement offer, aimed at advancing its Grace Project in Western Australia. The offer includes new shares priced at $0.018 each and free attaching options, with proceeds earmarked for drilling, studies, and working capital.

The Supreme Court of Western Australia has approved Gold Fields’ acquisition of Gold Road Resources via a scheme of arrangement, setting the stage for a significant consolidation in the gold mining sector.

Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.

Recce Pharmaceuticals has initiated patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, targeting a significant market with high diabetes prevalence. Interim results expected in early 2026 could accelerate regulatory approval and commercial launch.